{
}
Navina has secured $55 million in Series C funding led by Growth Equity at Goldman Sachs Alternatives, bringing its total funding to $100 million. This investment will enhance Navina's AI-powered clinical intelligence platform, aiming to improve patient care and outcomes across the U.S. healthcare market. With over 10,000 healthcare professionals using its technology, Navina is positioned to revolutionize value-based care by providing real-time insights that streamline workflows and reduce administrative burdens.
Terrance Brook Gammon
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
navina secures 55 million series c funding to enhance ai clinical platform
The Goldman Sachs Group, Inc.
USA
Joseph Allen Stein
Terrance Brook Gammon
Ronen Lavi
Irit Kahan
Show more
12:00 25.03.2025
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Banking Regulations
Global Financial Events
Retail and Consumer Goods
Finance Mergers & Acquisitions
Industry Mergers & Acquisitions
CEO Changes
Workplace Trends
Central Bank Actions
Market Analysis and Predictions
Global Trade Developments
Financial Scams and Security
Government Policies
GDP Growth & Recession Forecasts
Inflation and Monetary Impact
Supply Chain Management
Government Economic Policies
Startups & Entrepreneurship
Countries:
Companies:
JPMorgan Chase & Co.
The Goldman Sachs Group, Inc.
Tesla, Inc.
Barclays PLC
Apple Inc.
Deutsche Bank Money Market PP
Bank of America Corporation
Credit Suisse Lux Digital Healt
Citigroup Inc.
Wells Fargo & Company
UBS Group AG
BNP Paribas SA
Banco Santander, S.A.
Morgan Stanley
Lloyds Banking Group plc
Commerzbank AG
UniCredit S.p.A.
Huawei Technologies CO. Ltd.
SpaceXCoin USD
Berkshire Hathaway Inc.
Currencies:
United States Dollar
Euro
British Pound Sterling
Chinese Yuan
Swiss Franc
Japanese Yen
Indian Rupee
Australian Dollar
Russian Ruble
Danish Krone
Canadian Dollar
Mexican Peso
United Arab Emirates Dirham
South Korean Won
Offshore Chinese Yuan
Hong Kong Dollar
Indonesian Rupiah
Saudi Riyal
Turkish Lira
Malaysian Ringgit
People: